St. Jude Medical News
Most Popular St. Jude Medical Story
St. Jude touts positive Fame II study results; safety board urges enrollment halt
Good news from St. Jude Medical ($STJ) this morning. A data safety monitoring board has recommended that investigators halt enrollment in the Fame II study after seeing that fewer coronary artery Read more >>
Latest Headlines
- December 19, 2011
- November 29, 2011
- October 31, 2011
- October 19, 2011
- September 26, 2011
- September 7, 2011
- July 22, 2011
- July 20, 2011
- May 3, 2011
- April 25, 2011
- April 24, 2011
- April 20, 2011
- April 14, 2011
- April 11, 2011
- April 4, 2011
- March 29, 2011
- March 22, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
